A PEER-REVIEWED JOURNAL OF RESEARCH AND CLINICAL MEDICINEISSN 1727-2378 (Print)         ISSN 2713-2994 (Online)
Ru
En

Cervical Screening

DOI:10.31550/1727-2378-2021-20-1-56-60
For citation: Artymuk N.V. Cervical Screening. Doctor.Ru. 2021; 20(1): 56–60. (in Russian). DOI: 10.31550/1727-2378-2021-20-1-56-60
12 March 08:12

Objective of the Review: To analyse up-to-date publications and regulatory framework regarding cervical screening in the Russian Federation.

Key Points. Efficient cervical screening is an essential part of secondary cervical cancer prevention and can contribute to reduced mortality from cervical cancer. Currently, human papilloma virus (HPV) typing is the most promising area in cervical cancer screening, both in developed and developing states. Screening can be efficient only with the coverage of at least 80%; it is possible also with self-collection of material. The regulatory framework for cervical screening in the Russian Federation requires standardization.

Conclusion. The most efficient approach in prevention of cervical cancer mortality is HPV-oriented screening. The regulatory framework for cervical screening in the Russian Federation needs rework and alignment with up-to-date ideas.

Conflict of interest: The author declares that she does not have any conflict of interests.

N.V. Artymuk — Kemerovo State Medical University of the Ministry of Health of the Russian Federation; 22a Voroshilov Str., Kemerovo, Russian Federation 650029. eLIBRARY.RU SPIN: 7348-9673. https://orcid.org/0000-0001-7014-6492. E-mail: artymuk@gmail.com

Доктор.ру

Received: 24.12.2021
Accepted: 12.02.2021

12 March 08:12
LITERATURE
  1. Kaprin A.D., Starinskiy V.V., Petrova G.V., eds. Cancer aid to patients in Russia in 2019. M.: Herzen Scientific Research Institute, Federal Research Centre for Radiology, Ministry of Health of Russia; 2020. 236 p. (in Russian)
  2. Adamyan L.V., Artymuk N.V., Belokrinitskaya T.E. et al. Benign and premalignant cervical disorders: cervical cancer prevention. Clinical recommendations (treatment regimens). Russian Journal of Human Reproduction. 2018; 24(S6): 775–802. (in Russian)
  3. Arbyn M., Weiderpass E., Bruni L. et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob. Health. 2020; 8(2): e191–203. DOI: 10.1016/S2214-109X(19)30482-6
  4. Gradishar W.J., Anderson B.O., Balassanian R. et al. NCCN Guidelines Insights: breast cancer. Version 1.2017. J. Natl. Compr. Canc. Netw. 2017; 15(4): 433–51. DOI: 10.6004/jnccn.2017.0044
  5. Musa J., Achenbach C.J., O'Dwyer L.C. et al. Effect of cervical cancer education and provider recommendation for screening on screening rates: a systematic review and meta-analysis. PLoS One. 2017; 12(9): e0183924. DOI: 10.1371/journal.pone.0183924
  6. Smith R.A., Andrews K.S., Brooks D. et al. Cancer screening in the United States, 2019: a review of current American Cancer Society guidelines and current issues in cancer screening. CA Cancer J. Clin. 2019; 69(3): 184–210. DOI: 10.3322/caac.21557
  7. Peterson E.B., Ostroff J.S., DuHamel K.N. et al. Impact of provider-patient communication on cancer screening adherence: a systematic review. Prev. Med. 2016; 93: 96–105. DOI: 10.1016/j.ypmed.2016.09.034
  8. Artymuk N.V., Marochko K.V. Predictive value of different diagnostic methods for detection of cervical intraepithelial neoplasia and cervical cancer. Lietuvos Akušerija ir Ginekologija. 2017; 20(3): 222–7.
  9. Polman N.J., Snijders P.J.F., Kenter G.G. et al. HPV-based cervical screening: rationale, expectations and future perspectives of the new Dutch screening programme. Prev. Med. 2019; 119: 108–17. DOI: 10.1016/j.ypmed.2018.12.021
  10. Sawaya G.F., Smith-McCune K., Kuppermann M. Cervical cancer screening: more choices in 2019. JAMA. 2019; 321(20): 2018–19. DOI: 10.1001/jama.2019.4595
  11. Pankaj S., Nazneen S., Kumari S. et al. Comparison of conventional Pap smear and liquid-based cytology: a study of cervical cancer screening at a tertiary care center in Bihar. Indian J. Cancer. 2018; 55(1): 80–3. DOI: 10.4103/ijc.IJC_352_17
  12. Jeong H., Hong S.R., Chae S.W. et al. Comparison of unsatisfactory samples from conventional smear versus liquid-based cytology in uterine cervical cancer screening test. J. Pathol. Transl. Med. 2017; 51(3): 314–19. DOI: 10.4132/jptm.2017.03.17
  13. Bujan Rivera J., Klug S.J. Gebärmutterhalskrebsscreening in Deutschland [Cervical cancer screening in Germany]. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2018; 61(12): 1528–35. Doi: 10.1007/s00103-018-2835-7
  14. Kolomiets L.A., Churuksaeva O.N., Urazova L.N. et al. HPV vaccination: primary cervical cancer prevention. Tomsk: Printing manufactory; 2011. 116 p. (in Russian)
  15. Mustafa R.A., Santesso N., Khatib R. et al. Systematic reviews and meta-analyses of the accuracy of HPV tests, visual inspection with acetic acid, cytology, and colposcopy. Int. J. Gynaecol. Obstet. 2016; 132(3): 259–65. DOI: 10.1016/j.ijgo.2015.07.024
  16. Tomen E.A., Yohanna S., Obilom R.E. Awareness of Papanicolaou smear and visual inspection with acetic acid as screening tools for cervical cancer among women attending the general outpatient clinic of a tertiary institution in North Central Nigeria. Niger. Med. J. 2019; 60(2): 76–9. DOI: 10.4103/nmj.NMJ_16_19
  17. US Preventive Services Task Force; Curry S.J., Krist A.H. et al. Screening for cervical cancer: US Preventive Services Task Force recommendation statement. JAMA. 2018; 320(7): 674–86. DOI: 10.1001/jama.2018.10897
  18. Ogilvie G.S., van Niekerk D., Krajden M. et al. Effect of screening with primary cervical HPV testing vs cytology testing on high-grade cervical intraepithelial neoplasia at 48 months: the HPV focal randomized clinical trial. JAMA. 2018; 320(1): 43–52. DOI: 10.1001/jama.2018.7464
  19. Toliman P.J., Kaldor J.M., Tabrizi S.N. et al. Innovative approaches to cervical cancer screening in low- and middle-income countries. Climacteric. 2018; 21(3): 235–8. DOI: 10.1080/13697137.2018.1439917
  20. Sasaki Y., Iwanari O., Arakawa I. et al. Cervical cancer screening with human papillomavirus DNA and cytology in Japan. Int. J. Gynecol. Cancer. 2017; 27(3): 523–9. DOI: 10.1097/IGC.0000000000000898
  21. Lim A.W., Landy R., Castanon A. et al. Cytology in the diagnosis of cervical cancer in symptomatic young women: a retrospective review. Br. J. Gen. Pract. 2016; 66(653): e871–9. DOI: 10.3399/bjgp16X687937
  22. Bedell S.L., Goldstein L.S., Goldstein A.R. et al. Cervical cancer screening: past, present, and future. Sex Med. Rev. 2020; 8(1): 28–37. DOI: 10.1016/j.sxmr.2019.09.005
  23. Maver P.J., Poljak M. Primary HPV-based cervical cancer screening in Europe: implementation status, challenges, and future plans. Clin. Microbiol. Infect. 2020; 26(5): 579–83. DOI: 10.1016/j.cmi.2019.09.006
  24. Jin X.W., Lipold L., Foucher J. et al. Cost-effectiveness of primary HPV testing, cytology and co-testing as cervical cancer screening for women above age 30 years. J. Gen. Intern. Med. 2016; 31(11): 1338–44. DOI: 10.1007/s11606-016-3772-5
  25. Arrossi S., Thouyaret L., Herrero R. et al. Effect of self-collection of HPV DNA offered by community health workers at home visits on uptake of screening for cervical cancer (the EMA study): a population-based cluster-randomised trial. Lancet Glob. Health. 2015; 3(2): e85–94. DOI: 10.1016/S2214-109X(14)70354-7
  26. Nelson E.J., Maynard B.R., Loux T. et al. The acceptability of self-sampled screening for HPV DNA: a systematic review and meta-analysis. Sex. Transm. Infect. 2017; 93(1): 56–61. DOI: 10.1136/sextrans-2016-052609
  27. El-Zein M., Bouten S., Louvanto K. et al. Validation of a new HPV self-sampling device for cervical cancer screening: the cervical and self-sample in screening (CASSIS) study. Gynecol. Oncol. 2018; 149(3): 491–7. DOI: 10.1016/j.ygyno.2018.04.004
  28. Madzima T.R., Vahabi M., Lofters A. Emerging role of HPV self-sampling in cervical cancer screening for hard-to-reach women: focused literature review. Can. Fam. Physician. 2017; 63(8): 597–601.
  29. Nodjikouambaye Z.A., Adawaye C., Mboumba Bouassa R.S. et al. A systematic review of self-sampling for HPV testing in Africa. Int. J. Gynaecol. Obstet. 2020; 149(2): 123–9. DOI: 10.1002/ijgo.13112
  30. Boggan J.C., Walmer D.K., Henderson G. et al. Vaginal self-sampling for human papillomavirus infection as a primary cervical cancer screening tool in a Haitian population. Sex. Transm. Dis. 2015; 42(11): 655–9. DOI: 10.1097/OLQ.0000000000000345
  31. Kohler R.E., Elliott T., Monare B. et al. HPV self-sampling acceptability and preferences among women living with HIV in Botswana. Int. J. Gynaecol. Obstet. 2019; 147(3): 332–8. DOI: 10.1002/ijgo.12963
  32. Artymuk N.V., Marochko K.V. The effectiveness of different methods in the detection of high-grade squamous intraepithelial lesions of cervix uteri. Obstetrics and Gynecology. News. Views. Education. 2017; 4(18): 58–62. (in Russian)
  33. Marochko K.V., Artymuk N.V., Belokrinitskaya T.E. et al. Using vaginal self-sampling devices for detection of high-risk human papillomavirus. Fundamental and Clinical Medicine. 2018; 3(3): 78–83. (in Russian)
  34. Apolikhina I.A., Bashirova L.K., Letnikova L.I. et al. Evaluation of human papillomavirus infection in women in the Lipetsk Region, by using a diagnostic self-sampling test. Obstetrics and Gynecology. 2018; 11: 98–104. (in Russian). DOI: 10.18565/aig.2018.11.98-104
  35. Belokrinitskaya T.E., Frolova N.I., Turanova O.V. et al. The effectiveness and acceptability of screening for human papillomavirus in self- and medical sampling of vaginal discharge. Obstetrics and Gynecology. 2017; 2: 97–105. (in Russian). DOI: 10.18565/aig.2017.2.97-105
  36. Belokrinitskaya T.E., Frolova N.I., Turanova O.V. et al. Self-sampling vs physician sampling for HPV testing: informative value and acceptability in female patients of various ages. Doctor.Ru. 2017; 7(136): 8–14. (in Russian)
  37. Kira E.F., Semenova K.E., Bobrova M.V. et al. Optimization of screening for vaginal infections associated with human papillomaviruses. Obstetrics and Gynecology. 2018; 8: 167–73. (in Russian). DOI: 10.18565/aig.2018.8.167-173
  38. Yeh P.T., Kennedy C.E., de Vuyst H. et al. Self-sampling for human papillomavirus (HPV) testing: a systematic review and meta-analysis. BMJ Glob. Health. 2019; 4(3): e001351. DOI: 10.1136/bmjgh-2018-001351
  39. Artymuk N.V., Marochko K.V. The prevalence of the human papillomavirus infection among female prisoners in Siberia. Eur. J. Contraception Reprod. Health Care. 2016; 21(S1): 133.
  40. Adamyan L.V., Artymuk N.V., Ashrafyan L.A. et al. Benign and premalignant cervical disorders: cancer prevention. Clinical recommendations (diagnosis and management regimens) М.; 2017. 60 p. (in Russian)
  41. Adamyan L.V., Apolikhina I.A., Artymuk N.V. et al. Clinical recommendations. Cervical intraepithelial neoplasia, cervical erosion and ectopion. М.; 2020. 59 p. (in Russian)
  42. Aydogan Kirmizi D., Baser E., Demir Caltekin M. et al. Concordance of HPV, conventional smear, colposcopy, and conization results in cervical dysplasia. Diagn. Cytopathol. 2021; 49(1): 132–9. DOI: 10.1002/dc.24655

News

30 June 00:00
A New Issue of Doctor.Ru Neurology Psychiatry, Vol. 20, No. 5 (2021), Published

Find original articles and reviews covering various aspects of neurology, psychiatry and the interview with Professor Marina Arkadievna Kinkulkina

28 June 00:00
A New Issue of Doctor.Ru Internal Medicine, Vol. 20, No. 4 (2021), Published

Find original articles and reviews covering various aspects of cardiology, gastroenterology, internal medicine and the interview with Professor Elena Zelikovna Golukhova

 

3 May 17:06
A New Issue of Doctor.Ru Pediatrics, Vol. 20, No. 3 (2021), Published

Find original articles and reviews covering various aspects of pediatrics and the interview with Professor Evgeny Grigorievich Furman

3 May 17:06
A New Issue of Doctor.Ru Endocrinology, Vol. 20, No. 2 (2021), Published

Find original articles and reviews covering various aspects of endocrinology and the interview with Professor Valentin Viktorovich Fadeev

16 April 11:57
Igor Evgenievich Khatkov joined the American Surgical Association

Igor Evgenievich Khatkov, Head of A. S. Loginov Moscow Clinical Scientific and Practical Centre, Chief Oncologist in and for Moscow is now an honoured member of the American Surgical Association.

All news